SE421695B - Sett att framstella piperazinylpyraziner - Google Patents

Sett att framstella piperazinylpyraziner

Info

Publication number
SE421695B
SE421695B SE7604093A SE7604093A SE421695B SE 421695 B SE421695 B SE 421695B SE 7604093 A SE7604093 A SE 7604093A SE 7604093 A SE7604093 A SE 7604093A SE 421695 B SE421695 B SE 421695B
Authority
SE
Sweden
Prior art keywords
make
pyrazines
piperazinyl
piperazinyl pyrazines
make piperazinyl
Prior art date
Application number
SE7604093A
Other languages
English (en)
Swedish (sv)
Other versions
SE7604093L (sv
Inventor
W S Saari
Jr W C Lumma
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SE7604093L publication Critical patent/SE7604093L/xx
Publication of SE421695B publication Critical patent/SE421695B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7604093A 1975-04-21 1976-04-07 Sett att framstella piperazinylpyraziner SE421695B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57005275A 1975-04-21 1975-04-21

Publications (2)

Publication Number Publication Date
SE7604093L SE7604093L (sv) 1976-10-22
SE421695B true SE421695B (sv) 1982-01-25

Family

ID=24277994

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7604093A SE421695B (sv) 1975-04-21 1976-04-07 Sett att framstella piperazinylpyraziner

Country Status (36)

Country Link
JP (1) JPS51136688A (xx)
AR (1) AR210349A1 (xx)
AT (1) AT353795B (xx)
AU (1) AU496854B2 (xx)
BE (1) BE840904A (xx)
BG (1) BG34185A3 (xx)
CA (1) CA1059128A (xx)
CH (1) CH619462A5 (xx)
CS (1) CS195726B2 (xx)
CY (1) CY1090A (xx)
DD (1) DD124599A5 (xx)
DE (1) DE2617205C3 (xx)
DK (1) DK143899C (xx)
EG (1) EG12387A (xx)
ES (4) ES447150A1 (xx)
FI (1) FI62666C (xx)
FR (1) FR2308367A1 (xx)
GB (1) GB1492528A (xx)
GR (1) GR59900B (xx)
HK (1) HK60380A (xx)
HU (1) HU172684B (xx)
IE (1) IE42979B1 (xx)
IL (1) IL49391A (xx)
KE (1) KE3088A (xx)
LU (1) LU74795A1 (xx)
MY (1) MY8100225A (xx)
NL (1) NL167692C (xx)
NO (1) NO146599C (xx)
PH (1) PH12274A (xx)
PL (1) PL99664B1 (xx)
PT (1) PT65027B (xx)
RO (1) RO73278A (xx)
SE (1) SE421695B (xx)
SU (1) SU638260A3 (xx)
YU (1) YU100676A (xx)
ZA (1) ZA762320B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4091098A (en) * 1977-04-25 1978-05-23 Merck & Co., Inc. 3-(1-PIPERAZINYL)-1,2,4-BENZOTRIAZINES AND N-oxides
US4163849A (en) 1978-03-17 1979-08-07 Merck & Co., Inc. Piperazinylpyrazines
US4252816A (en) * 1979-12-03 1981-02-24 Merck & Co., Inc. Tetrahydro-1H-1,4-diazepino(1,7-a)benzimidazoles useful as analgesic agents
US4339579A (en) 1980-12-29 1982-07-13 American Home Products Corporation 2,6-Bis-(pyrrolopyrazinyl)pyrazines
EP0094498A3 (en) * 1982-05-06 1985-04-03 American Cyanamid Company Antiatherosclerotic 1-piperazine derivatives
US4547505A (en) * 1983-03-25 1985-10-15 Degussa Aktiengesellschaft N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production
US4788290A (en) * 1987-12-11 1988-11-29 American Home Products Corporation Serotonergic pyrazine derivatives
EP0580465A1 (fr) * 1992-06-25 1994-01-26 Sanofi Nouvelle utilisation thérapeutique d'hétérocyclyl-pipérazines comme 5-HT3 agonistes et nouveaux dérivés
DK1027336T3 (da) * 1997-10-27 2005-01-24 Neurosearch As Heteroaryldiazacycloalkaner, deres fremstilling og anvendelse
NZ514021A (en) 1999-04-26 2001-09-28 Neurosearch As Heteroaryl diazacycloalkanes, their preparation and use
BR0108363A (pt) * 2000-02-16 2004-02-10 Neurogen Corp Composto, métodos para modular função de receptor de crf e acoplado a proteìna g, para tratar um distúrbio ou doença do snc, para localizar receptores de crf em amostras de seção de tecidos, para inibir a ligação de crf a um receptor de crf¹ e para alterar a atividade de transdução de sinal de um receptor de crf¹ e composição farmacêutica
US6825198B2 (en) * 2001-06-21 2004-11-30 Pfizer Inc 5-HT receptor ligands and uses thereof
SE0202287D0 (sv) * 2002-07-19 2002-07-19 Biovitrum Ab New compounds
DE60311822T2 (de) * 2002-07-19 2007-12-06 Biovitrum Ab Neue piperazinyl-pyrazinon-derivate zur behandlung von 5-ht2a rezeptor-bedingten erkrankungen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2606906A (en) * 1948-10-14 1952-08-12 American Cyanamid Co 1-(2-pyridyl) piperazine and process of preparing same

Also Published As

Publication number Publication date
HK60380A (en) 1980-11-07
DE2617205A1 (de) 1976-10-28
NL167692C (nl) 1982-01-18
EG12387A (en) 1978-12-31
ATA288376A (de) 1979-05-15
KE3088A (en) 1980-11-07
ES459407A1 (es) 1978-08-16
NO146599B (no) 1982-07-26
IL49391A (en) 1979-09-30
NO761207L (xx) 1976-10-22
BG34185A3 (en) 1983-07-15
AU1296676A (en) 1977-10-20
JPS51136688A (en) 1976-11-26
DE2617205B2 (de) 1980-05-08
FI62666C (fi) 1983-02-10
NL167692B (nl) 1981-08-17
PT65027B (en) 1978-04-03
AT353795B (de) 1979-12-10
LU74795A1 (xx) 1977-02-07
ES459406A1 (es) 1978-08-16
DK143899C (da) 1982-04-13
AU496854B2 (en) 1978-11-02
ZA762320B (en) 1977-11-30
GR59900B (en) 1978-03-16
DK143899B (da) 1981-10-26
BE840904A (fr) 1976-08-16
IE42979L (en) 1976-10-21
CY1090A (en) 1980-12-27
FI760978A (xx) 1976-10-22
MY8100225A (en) 1981-12-31
DK164476A (da) 1976-10-22
JPS5522475B2 (xx) 1980-06-17
ES447150A1 (es) 1977-09-16
DD124599A5 (xx) 1977-03-02
GB1492528A (en) 1977-11-23
PT65027A (en) 1976-05-01
CA1059128A (en) 1979-07-24
RO73278A (ro) 1982-09-09
AR210349A1 (es) 1977-07-29
YU100676A (en) 1982-08-31
SU638260A3 (ru) 1978-12-15
PH12274A (en) 1978-12-12
PL99664B1 (pl) 1978-07-31
NO146599C (no) 1982-11-03
CS195726B2 (en) 1980-02-29
FR2308367A1 (fr) 1976-11-19
FR2308367B1 (xx) 1979-09-21
IE42979B1 (en) 1980-11-19
NL7603800A (nl) 1976-10-25
HU172684B (hu) 1978-11-28
IL49391A0 (en) 1976-06-30
DE2617205C3 (de) 1981-01-29
CH619462A5 (en) 1980-09-30
FI62666B (fi) 1982-10-29
SE7604093L (sv) 1976-10-22
ES459405A1 (es) 1978-08-16

Similar Documents

Publication Publication Date Title
SE433222B (sv) Sett att framstella modifierad polysackarid
SE432247B (sv) Sett att framstella dihydro-cyklosporin c
SE418473B (sv) Sett att tillverka patronhylsor
SE422077B (sv) Sett att framstella syntesgas
SE7600277L (sv) Sett att framstella sampolymerisatpulver
SE7606280L (sv) Sett att framstella etrar
SE440779B (sv) Sett att framstella androstan-17-on-derivat
SE433492B (sv) Sett att framstella fenylettiksyraderivat
SE425736B (sv) Sett att framstella kromanon-(4)
SE420728B (sv) Sett att framstella piperazinyliminorifamyciner
SE421695B (sv) Sett att framstella piperazinylpyraziner
SE432256B (sv) Sett att framstella cellulosaalkyletrar
SE427111B (sv) Sett att framstella pilokarpiniumsalter
SE417816B (sv) Sett att framstella expanderad slagg
SE430687B (sv) Sett att framstella hexanitrostilben
SE420732B (sv) Sett att framstella 4-gonen-3-oner
SE424991B (sv) Sett att framstella nya 5-fenyl-oxazolidinoner
SE420729B (sv) Sett att framstella substituerade piperazinyliminorifamyciner
SE430156B (sv) Sett att framstella 2-subst-1-(omega-aminoalkoxi)-bensener
SE7607171L (sv) Sett att framstella indolokinoliziner
SE420690B (sv) Sett att kontinuerligt framstella vermeisolerande ledningsror
SE7603895L (sv) Sett att framstella skumplaster
SE433213B (sv) Sett att framstella 2 -fenyl-3-amino-benso/b/tiofenderivat
SE420731B (sv) Sett att framstella 5-androsten-17-on-derivat
SE418249B (sv) Sett att framstella agglomerat

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7604093-0

Effective date: 19911108

Format of ref document f/p: F